Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 4
2021 4
2022 3
2023 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
A human liver organoid screening platform for DILI risk prediction.
Zhang CJ, Meyer SR, O'Meara MJ, Huang S, Capeling MM, Ferrer-Torres D, Childs CJ, Spence JR, Fontana RJ, Sexton JZ. Zhang CJ, et al. J Hepatol. 2023 May;78(5):998-1006. doi: 10.1016/j.jhep.2023.01.019. Epub 2023 Feb 3. J Hepatol. 2023. PMID: 36738840 Free PMC article.
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
Qiao Y, Wotring JW, Zheng Y, Zhang CJ, Zhang Y, Jiang X, Pretto CD, Eyunni S, Parolia A, He T, Cheng C, Cao X, Wang R, Su F, Ellison SJ, Wang Y, Qin J, Yan H, Zhou Q, Ma L, Sexton JZ, Chinnaiyan AM. Qiao Y, et al. Proc Natl Acad Sci U S A. 2023 Jul 25;120(30):e2221809120. doi: 10.1073/pnas.2221809120. Epub 2023 Jul 17. Proc Natl Acad Sci U S A. 2023. PMID: 37459541 Free PMC article.
Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection.
Qiao Y, Wotring JW, Zhang CJ, Jiang X, Xiao L, Watt A, Gattis D, Scandalis E, Freier S, Zheng Y, Pretto CD, Ellison SJ, Swayze EE, Guo S, Sexton JZ, Chinnaiyan AM. Qiao Y, et al. PLoS One. 2023 Feb 3;18(2):e0281281. doi: 10.1371/journal.pone.0281281. eCollection 2023. PLoS One. 2023. PMID: 36735698 Free PMC article.
In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment.
Wotring JW, McCarty SM, Shafiq K, Zhang CJ, Nguyen T, Meyer SR, Fursmidt R, Mirabelli C, Clasby MC, Wobus CE, O'Meara MJ, Sexton JZ. Wotring JW, et al. bioRxiv [Preprint]. 2022 Jul 13:2022.06.24.497526. doi: 10.1101/2022.06.24.497526. bioRxiv. 2022. Update in: Vaccines (Basel). 2022 Aug 09;10(8):1284. doi: 10.3390/vaccines10081284 PMID: 35860224 Free PMC article. Updated. Preprint.
ARF6 is a host factor for SARS-CoV-2 infection in vitro.
Mirabelli C, Bragazzi Cunha J, Wotring JW, Sherman EJ, El Saghir J, Harder J, Kretzler M, Sexton JZ, Emmer BT, Wobus CE. Mirabelli C, et al. J Gen Virol. 2023 Jun;104(6):001868. doi: 10.1099/jgv.0.001868. J Gen Virol. 2023. PMID: 37342971 Free PMC article.
16 results